Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
Clinical trial NCT07776054 · RECRUITING
Trial details
- NCT number
- NCT07776054
- Sponsor
- Samsung Medical Center
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2027-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.